Stock Analysts’ Updated EPS Estimates for April, 17th (AD, AERI, BDI, CFP, HBM, PRTA, SPE, TCP, THS, TROX)

Stock Analysts’ updated eps estimates for Tuesday, April 17th:

Alaris Royalty (TSE:AD) was upgraded by analysts at Desjardins from a hold rating to a buy rating.

How to Become a New Pot Stock Millionaire

Aerie Pharmaceuticals (NASDAQ:AERI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Aerie received a significant boost with the recent approval of lead drug Rhopressa. The approval came ahead of the PDUFA date. Meanwhile, Aerie is also evaluating Roclatan, a once-daily, quadruple action fixed-dose combination of Rhopressa and Xalatan. Aerie’s shares have outperformed the industry in the last  twelve months. However, Rhopressa faces stiff competition from established branded and generic pharmaceutical companies, such as Novartis’ Simbrinza and Travtan, and Allergan’s Lumigan, as well as other smaller biotechnology and pharmaceutical companies. Valeant Pharmaceutical’s Vyzulta is also approved for open-angle glaucoma or ocular hypertension. Rhopressa will face a tough time in gaining market share due to competition from these products. Any approval delays for Roclatan like Rhopressa will be detrimental to the company's growth prospects.”

Black Diamond Group (TSE:BDI) was downgraded by analysts at Raymond James Financial from an outperform rating to a market perform rating. The firm currently has C$2.40 target price on the stock, down from their previous target price of C$2.45.

Canfor (TSE:CFP) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has C$39.00 price target on the stock, up from their previous price target of C$33.00.

Hudbay Minerals (TSE:HBM) (NYSE:HBM) was downgraded by analysts at TD Securities from an action list buy rating to a buy rating. The firm currently has C$14.50 target price on the stock, down from their previous target price of C$15.00.

Prothena (NASDAQ:PRTA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $43.00 price target on the stock. According to Zacks, “Prothena’s efforts to develop its pipeline are encouraging as late stage candidate, NEOD001 looks promising and a potential approval will boost prospects. Moreover, Prothena's license agreement with Roche for the development and commercialization of selected antibodies targeting alpha-synuclein is a big positive as it not only boosts pipeline development but also provides it with funds in the form of research reimbursement and milestone payments. The company recently entered into an agreement with Celgene as well.  However, Prothena is highly dependent on its collaboration partners for the development of its candidates. The company itself does not have enough resources to independently conduct studies on its candidates. Due to disappointing data from a phase Ib study, the company will not advance PRX003 into mid-stage development. Shares have performed better than the industry in the last three months.”

Spartan Energy (TSE:SPE) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. The firm currently has C$7.00 target price on the stock, down from their previous target price of C$7.50.

Spartan Energy (TSE:SPE) was downgraded by analysts at National Bank Financial from an outperform rating to a sector perform rating. National Bank Financial currently has C$7.00 target price on the stock, down from their previous target price of C$9.00.

Spartan Energy (TSE:SPE) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. The firm currently has C$6.50 price target on the stock, down from their previous price target of C$8.00.

Spartan Energy (TSE:SPE) was downgraded by analysts at Scotiabank from an outperform rating to a tender rating. The firm currently has C$9.00 price target on the stock, down from their previous price target of C$13.00.

Spartan Energy (TSE:SPE) was downgraded by analysts at Raymond James Financial from an outperform rating to a market perform rating. The firm currently has C$6.50 price target on the stock, down from their previous price target of C$9.00.

TC PipeLines (NYSE:TCP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “We like TC PipeLines for its generation of stable, recurring and low-risk earnings and cash flows. TC PipeLines’ long history of stable and growing cash distributions has delivered value to its investors. Moreover, the partnership’s recent agreement to purchase interests in the Iroquois Gas Transmission System is likely to strengthen its cash flow and earnings further. However, we are concerned of the lower natural gas volumes in its Northern Border Pipeline along with substantial uncontracted capacity at Great Lakes. Further, uncertainty over the energy infrastructure provider's dropdown prospects has dampened investor sentiment on the stock of late. As such, units of the partnership have declined 37.6% in the last three months, wider than the industry’s loss of 11.7%. Thus, we see limited upside from current levels and take a cautious stance on TCP units.”

TreeHouse Foods (NYSE:THS) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “TreeHouse Foods, which has lagged the industry in a year, has been bearing the brunt of pricing pressure stemming from stiff competition in the grocery industry. This, along with commodity cost inflation and rising freight costs has been marring TreeHouse Foods’ DOI margin for a while now. This was reflected in fourth-quarter 2017 results, which marked the company’s third straight quarter of year-over-year earnings and sales decline. Nonetheless, the company remains on track with TreeHouse 2020 plan that aims to boost operating margin by 300 bps by the end of 2020, through complete business integration and cost reduction. Also, TreeHouse completed a review of its SG&A and related costs and expects 2018 savings of roughly $30 million. Moreover, the company has been undertaking acquisitions to augment its portfolio, alongside of enhanced focus on organic food offerings.”

Tronox (OTCMKTS:TROX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $22.00 target price on the stock. According to Zacks, “Tronox Incorporated is a producer and marketer of titanium products. Products offered by the Company includes: titanium ore and titanium dioxide (TiO2); mineral sands products; and electrolytic and speciality chemicals. Titanium products offered by Tronox find its application in paints, coatings and plastics. The electrolytic and specialty chemicals find s application in the paper and battery industries. Tronox’s mineral sands operations consist of two product streams – titanium feedstock, which includes ilmenite, natural rutile, titanium slag and synthetic rutile; and zircon, which is contained in the mineral sands extracted to capture natural titanium feedstock. Tronox operates three separate mining operations: KZN Sands and Namakwa Sands located in South Africa and Perth in Western Australia. Production of electrolytic and specialty chemicals is carried out in United States. Tronox Incorporated is based in Oklahoma City, Oklahoma. “

TransUnion (NYSE:TRU) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “TransUnion is poised for impressive growth in several of its end markets with an attractive business model, significant operating leverage, low capital requirements and strong and stable cash flows. Increased risk of identity theft due to data breaches and high consumer awareness are further propelling demand. TransUnion serves a broad range of customers across multiple geographies and verticals. As emerging market economies continue to develop and mature, the company is well-positioned to gain from the associated favorable socio-economic trends. The company has also outperformed the industry in the last six months. However, TransUnion operates in a highly competitive market, which restricts its pricing power and limits profitability to some extent.”

Under Armour (NYSE:UAA) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Shares of Under Armour have not only performed dismally on the bourses but have also underperformed the industry by a wide margin in a year. The stock is unlikely to pick up pace anytime soon as the company continues to witness sluggishness in North American business, declining gross margin and higher interest expenses. Further, investors’ sentiments were hurt by the company’s soft North American sales guidance for the full year. Bankruptcies, store closures, decreased productivity and demand along with change in fashion preference have been the major factors acting against the stock. However, Under Armour’s sustained focus on brand development, expansion of direct-to-consumer and technology-based fitness business bode well. Furthermore, the company continues to look for opportunities to expand global footprint and market share, apart from rolling out e-commerce platforms.”

Vermilion Energy (TSE:VET) (NYSE:VET) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. BMO Capital Markets currently has C$47.00 target price on the stock, down from their previous target price of C$50.00.

Receive News & Ratings for Alaris Royalty Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alaris Royalty Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Investors Sell Shares of Visa  on Strength
Investors Sell Shares of Visa on Strength
Investors Buy Shares of KeyCorp  on Weakness
Investors Buy Shares of KeyCorp on Weakness
Investors Buy Shares of FIS  on Weakness
Investors Buy Shares of FIS on Weakness
PiplCoin  Reaches 1-Day Volume of $60,801.00
PiplCoin Reaches 1-Day Volume of $60,801.00
IrishCoin  Trading 59.3% Higher  Over Last 7 Days
IrishCoin Trading 59.3% Higher Over Last 7 Days
Contrasting ManpowerGroup  and Dometic Group
Contrasting ManpowerGroup and Dometic Group


Leave a Reply

 
© 2006-2018 Zolmax.